Antisense Oligonucleotide (ASO) Development for Rare and Neglected Diseases

$1,066,904ZIAFY2024TRNIH

National Center For Advancing Translational Sciences

Investigators

Elizabeth Ottingercontact

Linked publications, trials & patents

Paper 35075291 Patent 12398185 Patent 11884730 Patent 11124571 Patent 10453191

View original record on NIH RePORTER →

Antisense Oligonucleotide (ASO) Development for Rare and Neglected Diseases · GrantIndex